Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC |
Cilinski LynnVP, Controller and Treasurer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 7,989 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · derivative · entry 7 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,989 shares Expires 2023-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC |
Cilinski LynnVP, Controller and Treasurer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 7,989 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · derivative · entry 6 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,989 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC |
Cilinski LynnVP, Controller and Treasurer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 7,989 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · derivative · entry 5 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,989 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC |
Cilinski LynnVP, Controller and Treasurer
|
SaleCommon Stock | 23,967 | $25.01 | $599,436.24 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · nonDerivative · entry 4 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,923 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.14. The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC |
Cilinski LynnVP, Controller and Treasurer
|
Exercise / conversionCommon Stock | 7,989 | $1.51 | $12,063.39 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · nonDerivative · entry 3 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC |
Cilinski LynnVP, Controller and Treasurer
|
Exercise / conversionCommon Stock | 7,989 | $0.94 | $7,509.66 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · nonDerivative · entry 2 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC |
Cilinski LynnVP, Controller and Treasurer
|
Exercise / conversionCommon Stock | 7,989 | $0.94 | $7,509.66 |
DisclosureSEC source: 0001125345-18-000030 · wf-form4_151994303162848.xml · nonDerivative · entry 1 Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 1,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000031 · wf-form4_151994305645663.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,497 Underlying: Common Stock · 1,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 1,000 | $25.01 | $25,005.00 |
DisclosureSEC source: 0001125345-18-000031 · wf-form4_151994305645663.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.01.The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 1,000 | $0.94 | $940.00 |
DisclosureSEC source: 0001125345-18-000031 · wf-form4_151994305645663.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 22:49 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
Tax withholdingCommon Stock | 11,070 | $23.46 | $259,702.20 |
DisclosureSEC source: 0001125345-18-000027 · wf-form4_151977175494111.xml · nonDerivative · entry 1 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,930 F1 · shares: Represents shares of common stock withheld to pay taxes upon vesting of restricted stock units originally granted to the Reporting Person on 2/25/16. The number of shares withheld was determined on 2/26/18 based on the closing price of Company common stock on that day. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 22:22 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000012 · wf-form4_151691894605441.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,497 Underlying: Common Stock · 3,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 22:22 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 3,000 | $22.50 | $67,500.00 |
DisclosureSEC source: 0001125345-18-000012 · wf-form4_151691894605441.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 F1 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted 11/14/17. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.50 to $20.51. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 22:22 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 3,000 | $0.94 | $2,820.00 |
DisclosureSEC source: 0001125345-18-000012 · wf-form4_151691894605441.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:01 UTC Amendment |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000014 · wf-form4a_151700049576402.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,497 Underlying: Common Stock · 3,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:01 UTC Amendment |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 3,000 | $22.50 | $67,500.00 |
DisclosureSEC source: 0001125345-18-000014 · wf-form4a_151700049576402.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 F1 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted 11/14/17. F2 · price: The Form 4, as originally filed on 1/25/18, incorrectly reported the sale price. The Form 4, as amended by this Form 4/A, correctly reports such information. F3 · price: The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $22.50 to $22.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:01 UTC Amendment |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 3,000 | $0.94 | $2,820.00 |
DisclosureSEC source: 0001125345-18-000014 · wf-form4a_151700049576402.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:19 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 2,524 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001125345-18-000007 · wf-form4_151631396295775.xml · derivative · entry 6 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,448 Underlying: Common Stock · 2,524 shares Expires 2023-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:19 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
SaleCommon Stock | 2,524 | $20.00 | $50,480.00 |
DisclosureSEC source: 0001125345-18-000007 · wf-form4_151631396295775.xml · nonDerivative · entry 4 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F2 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $20 to $20.03. F1 · balance_after: This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:19 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
Exercise / conversionCommon Stock | 2,524 | $4.70 | $11,862.80 |
DisclosureSEC source: 0001125345-18-000007 · wf-form4_151631396295775.xml · nonDerivative · entry 3 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:19 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 2,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000006 · wf-form4_151631394773382.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,497 Underlying: Common Stock · 2,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:19 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 2,000 | $0.94 | $1,880.00 |
DisclosureSEC source: 0001125345-18-000006 · wf-form4_151631394773382.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This amount includes 1,100 shares purchased through the Company's ESPP; 800 on 5/31/17 and 300 on 11/30/17. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 22:19 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 6,516 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000008 · wf-form4_151631397852775.xml · derivative · entry 2 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,516 shares Expires 2018-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 22:19 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionCommon Stock | 6,516 | $0.94 | $6,125.04 |
DisclosureSEC source: 0001125345-18-000008 · wf-form4_151631397852775.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Owned jointly with reporting person's wife. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 22:19 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 2,476 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001125345-18-000007 · wf-form4_151631396295775.xml · derivative · entry 5 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,972 Underlying: Common Stock · 2,476 shares Expires 2023-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 22:19 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
SaleCommon Stock | 2,476 | $20.00 | $49,520.00 |
DisclosureSEC source: 0001125345-18-000007 · wf-form4_151631396295775.xml · nonDerivative · entry 2 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F2 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $20 to $20.71. F1 · balance_after: This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 22:19 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
Exercise / conversionCommon Stock | 2,476 | $4.70 | $11,637.20 |
DisclosureSEC source: 0001125345-18-000007 · wf-form4_151631396295775.xml · nonDerivative · entry 1 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 16:59 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000002 · wf-form4_151499874004997.xml · derivative · entry 2 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,516 Underlying: Common Stock · 3,000 shares Expires 2018-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 16:59 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionCommon Stock | 3,000 | $0.94 | $2,820.00 |
DisclosureSEC source: 0001125345-18-000002 · wf-form4_151499874004997.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Owned jointly with reporting person's wife. Read SEC document |
| November 21, 2017 Filed Nov 21, 2017 22:15 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 5,000 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001125345-17-000116 · wf-form4_151130253889619.xml · derivative · entry 3 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,448 Underlying: Common Stock · 5,000 shares Expires 2023-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2017 Filed Nov 21, 2017 22:15 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001125345-17-000116 · wf-form4_151130253889619.xml · nonDerivative · entry 2 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $20 to $20.03 F3 · balance_after: This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18. Read SEC document |
| November 21, 2017 Filed Nov 21, 2017 22:15 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
Exercise / conversionCommon Stock | 5,000 | $4.70 | $23,500.00 |
DisclosureSEC source: 0001125345-17-000116 · wf-form4_151130253889619.xml · nonDerivative · entry 1 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 23:21 UTC |
SIEGEL JAY PHILIPDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $17.85 | $0.00 |
DisclosureSEC source: 0001125345-17-000113 · wf-form4_151078806434853.xml · derivative · entry 1 SIEGEL JAY PHILIP · CIK 0001722857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2017-11-13 F1 · derivative.exercise_date: (1) The option will vest 1/12th of the shares monthly, beginning on the first monthly anniversary of the grant date and will become fully exercisable 1 year from the date of grant (11/13/18). Read SEC document |
| October 25, 2017 Filed Oct 26, 2017 13:37 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 10,000 | $4.70 Strike: $4.70 | $47,000.00 |
DisclosureSEC source: 0001125345-17-000099 · wf-form4_150902503619614.xml · derivative · entry 3 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,448 Underlying: Common Stock · 10,000 shares Expires 2023-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2017 Filed Oct 26, 2017 13:37 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
SaleCommon Stock | 10,000 | $20.00 | $200,000.00 |
DisclosureSEC source: 0001125345-17-000099 · wf-form4_150902503619614.xml · nonDerivative · entry 2 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017 F2 · price: This transaction was executed in multiple trades at prices ranging from $20 to $20.145. F3 · balance_after: This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18. Read SEC document |
| October 25, 2017 Filed Oct 26, 2017 13:37 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
Exercise / conversionCommon Stock | 10,000 | $4.70 | $47,000.00 |
DisclosureSEC source: 0001125345-17-000099 · wf-form4_150902503619614.xml · nonDerivative · entry 1 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 20:54 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-17-000097 · wf-form4_150481765495153.xml · derivative · entry 2 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,516 Underlying: Common Stock · 5,000 shares Expires 2018-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 20:54 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionCommon Stock | 5,000 | $0.94 | $4,700.00 |
DisclosureSEC source: 0001125345-17-000097 · wf-form4_150481765495153.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Owned jointly with reporting person's wife. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 20:52 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 2,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-17-000095 · wf-form4_150481753175250.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,497 Underlying: Common Stock · 2,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The total reported in Column 9 has been adjusted to correct a prior calculation error in the Form 4 filed by the reporting person on February 8, 2016, which understated the total number of shares. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 20:52 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 2,000 | $0.94 | $1,880.00 |
DisclosureSEC source: 0001125345-17-000095 · wf-form4_150481753175250.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 20:47 UTC |
Bonvini EzioSr VP, Research & CSO
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 26,632 | $0.94 Strike: $0.94 | $25,034.08 |
DisclosureSEC source: 0001125345-17-000085 · wf-form4_150118845634227.xml · derivative · entry 4 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,632 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 20:47 UTC |
Bonvini EzioSr VP, Research & CSO
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 26,632 | $1.51 Strike: $1.51 | $40,214.32 |
DisclosureSEC source: 0001125345-17-000085 · wf-form4_150118845634227.xml · derivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,632 shares Expires 2023-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 20:47 UTC |
Bonvini EzioSr VP, Research & CSO
|
Exercise / conversionCommon Stock | 26,632 | $0.94 | $25,034.08 |
DisclosureSEC source: 0001125345-17-000085 · wf-form4_150118845634227.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 20:47 UTC |
Bonvini EzioSr VP, Research & CSO
|
Exercise / conversionCommon Stock | 26,632 | $1.51 | $40,214.32 |
DisclosureSEC source: 0001125345-17-000085 · wf-form4_150118845634227.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 20:04 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 5,000 | $4.70 Strike: $4.70 | $23,500.00 |
DisclosureSEC source: 0001125345-17-000083 · wf-form4_149677942918537.xml · derivative · entry 3 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,448 Underlying: Common Stock · 5,000 shares Expires 2023-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 20:04 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001125345-17-000083 · wf-form4_149677942918537.xml · nonDerivative · entry 2 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2016. F2 · price: This transaction was executed in multiple trades at prices ranging from $20 to $20.02. F3 · balance_after: This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 20:04 UTC |
Wigginton Jon MarcSr VP, Clinical Dev. & CMO
|
Exercise / conversionCommon Stock | 5,000 | $4.70 | $23,500.00 |
DisclosureSEC source: 0001125345-17-000083 · wf-form4_149677942918537.xml · nonDerivative · entry 1 Wigginton Jon Marc · CIK 0001587487 · Sr VP, Clinical Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2017 Filed Feb 12, 2018 22:17 UTC |
Peters Jeffrey StuartActing General Counsel
|
GrantCommon Stock | 270 | $15.05 | $4,063.50 |
DisclosureSEC source: 0001125345-18-000018 · wf-form5_151847380869920.xml · nonDerivative · entry 1 Peters Jeffrey Stuart · CIK 0001706903 · Acting General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270 F1 · kind: The reporting person is voluntarily reporting the acquisition of the issuer's common stock pursuant to the MacroGenics, Inc. Employee Stock Purchase Plan. This acquisition was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 18, 2017 Filed May 22, 2017 23:02 UTC |
Jackson Scott ThomasDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $19.57 | $0.00 |
DisclosureSEC source: 0001125345-17-000080 · wf-form4_149549416283411.xml · derivative · entry 1 Jackson Scott Thomas · CIK 0001566617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-05-18 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
| May 18, 2017 Filed May 22, 2017 23:02 UTC |
STUMP DAVID CDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $19.57 | $0.00 |
DisclosureSEC source: 0001125345-17-000079 · wf-form4_149549414384083.xml · derivative · entry 1 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-05-18 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.